cas 6639-87-8|| where to buy 6-nitroquinoxaline

Nombre del producto:6-nitroquinoxaline

IUPAC Name:6-nitroquinoxaline

: CAS：6639-87-8; Fórmula molecular：C8H5N3O2; Pureza：95%

: Número de catálogo：CM100001; Peso molecular：175.15

Unidad de embalaje	Stock disponible	Precio($)
CM100001-5g	in stock	ǵƓ
CM100001-10g	in stock	ȃƓǵ
CM100001-25g	in stock	ŗŗƓ

Consulta: sales@chemenu.com

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 6639-87-8 regularly via the above email.

Notas adicionales

Verification code*

refresh

Detalles del producto

: Núm. De CAS :6639-87-8; Fórmula molecular:C8H5N3O2; Punto de fusión:-; Código de sonrisas:C1=CC2=NC=CN=C2C=C1[N+](=O)[O-]; Densidad:1.437g/cm3

: Número de catálogo:CM100001; Peso molecular:175.15; Punto de ebullición:; Nº Mdl:MFCD00462822; Almacenamiento:Store at room temperature.

Category Infos

: Quinoxalines; Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

Column Infos

: Quinoxalines

Product Other Information

Synthesis Method

6-Nitroquinoxaline can be synthesized in a two-step process. The first step involves the condensation of o-nitroaniline with ethyl acetoacetate in the presence of an acid catalyst to form the intermediate 2-methyl-6-nitroquinoxaline. This intermediate can then be reduced with sodium borohydride to yield 6-nitroquinoxaline.